The biotech industry includes bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share in this sector. Advancements in biotechnology have enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Scientific research and technological advancements have resulted in the emergence of various personalized medicines that are undergoing research. According to research conducted by the Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.

The biotechnology sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and disease prevention.

Key Challenges

Biotech products have extensive application in oncology and autoimmune disease treatment. However, the cost of these drugs is high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging owing to growing concern for safety of the drug.

Also, there is lack of awareness about personalized medicine among most healthcare providers, which may hamper its adoption. Clinical adoption of biotechnology products is essential for its success. However, it significant scientific evidence and backing is required to ensure its safety.

“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”

Tufts Center for the Study of Drug Development

Opportunities

The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to a growth in their demand, Furthermore, consumers are willing to pay high prices for biopharmaceutical products compared to other conventional products. Biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sale of over US$ 2bn. Drugs such as Humira have generated sales revenue of over US$ 10bn.

Governments in emerging economies are endorsing biosimilars as cost-effective alternatives to biotech products, which is expected to create significant growth opportunities for manufacturers of generic drugs. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:

Erbitux (cetuximab) - February 2016
Rituxan (rituximab) - September 2016
Herceptin (trastuzumab) - June 2019
Avastin (bevacizumab) - July 2019
Aranesp (darbepoetin alfa) - May 2024
Enbrel (etanercept) - November 2028

Companies such as Teva Pharmaceuticals, Hospira, Sandoz, and Amgen are focusing on development of biosimilars and vaccines as preventive measures in addition to treatment. For instance, in 2015, Zarxio TM became the first biosimilar to be approved in the U.S. market. The EMA approved Mosquirix, a malaria vaccine, in the same year. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.

Conclusion

The increasing research in the biotechnology sector is expected to result in higher number of biopharmaceutical products seeking FDA approvals. Biopharmaceuticals are positioned to be promising treatment solutions that would improve patient outcomes and help with reduction of the cost of drug development.View less

Specialty and Fine Chemicals

Cosmetic Ingredients

Food Ingredients

Aerospace and Defense

Automotive and Transportation

Consumer Electronics

Construction Engineering

Industrial Automation and Machinery

Semiconductors

Smart Technologies

Information and Communication Technology

Biotechnology Published Insights

Recombinant Vaccine Market

Published Date : Feb 2025

The Global Recombinant Vaccine Market is estimated to be valued at USD 12.52 Bn in 2025 and is expected to reach USD 27.17 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.7% from 2025 to 2032.Recombi... View more

Genetic Toxicology Testing Market

Published Date : Feb 2025

The global genetic toxicology testing market witnessed a steady growth during the historic period (2020-2028) and is projected to see positive gains in the forecast period (2025-2032. This can be primarily attributed to rising awareness about the safety assessment of ... View more

Global Cancer Therapeutics And Biotherapeutics Market

Published Date : Feb 2025

Cancer therapeutics and biotherapeutics is a large and growing market globally. While conventional treatment options such as chemotherapy have limitations, newer biological and targeted therapies are revolutionizing cancer treatment. Biological therapies harness the p... View more

Global Cell And Tissue Preservation Market

Published Date : Feb 2025

Cell and tissue preservation is the process of stabilizing and storing biological samples and specimens for future use in research, clinical applications, and diagnostic procedures. It helps maintain the structural integrity and biological functionality of cells and t... View more

Plant Tissue Culture Market

Published Date : Feb 2025

Global plant tissue culture market is witnessing significant growth due to growing adoption of tissue culture techniques for large-scale propagation of mature plantlets and hybrid varieties. Tissue culture provides a rapid means of mass multiplication of elite plants ... View more

Closed System Transfer Device Market

Published Date : Feb 2025

The closed system transfer device market is estimated to be valued at USD 1.63 Bn in 2025 and is expected to reach USD 4.82 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.7% from 2025 to 2032. Closed system t... View more

Microbiome Sequencing Service Market

Published Date : Feb 2025

Global microbiome sequencing service market is estimated to be valued at USD 2.19 Bn in 2025 and is expected to exhibit a CAGR of 11.3% during the forecast period (2025-2032). Microbiome sequencing involves using high-throughput sequencing technologies to study the ... View more

Downstream Processing Market

Published Date : Feb 2025

Downstream processing refers to the purification and recovery steps in bioprocessing undertaken after fermentation to isolate the active ingredient or product of interest from cellular biomass or fermentation broth. It involves clarification to remove cellular debris ... View more

Clinical Microbiology Market

Published Date : Feb 2025

Global clinical microbiology market is estimated to be valued at USD 5.26 Bn in 2025, and is expected to exhibit a CAGR of 5.6% during the forecast period (2025-2032). Global clinical microbiology market is witnessing strong growth due to increasing prevalence of in... View more

Global Sanger Sequencing Market

Published Date : Feb 2025

Global sanger sequencing market is estimated to be valued at USD 3,729.8 Mn in 2025, and is expected to exhibit a CAGR of 18.4% during the forecast period (2025-2032). Sanger sequencing, also known as chain termination or dideoxy sequencing, is a method for DNA sequ... View more

Global Canine Influenza Vaccine Market

Published Date : Feb 2025

The Global canine influenza vaccine market is estimated to be valued at USD 1,901.6 Mn in 2025, and is expected to exhibit a CAGR of 5.3% during the forecast period (2025-2032). Canine influenza, commonly known as dog flu, is a contagious respiratory disease caused ... View more

Glycomics Market

Published Date : Feb 2025

The global glycomics market is estimated to be valued at USD 2.26 BN in 2025 and is expected to exhibit a CAGR of 13.7% during the forecast period (2025-2032). Glycomics is the large-scale study of the entire complement of sugars, known as the glycome. Glycomics see... View more

Personalized Medicine Market

Published Date : Feb 2025

The global personalized medicine market is estimated to be valued at USD 89.15 BN in 2025 and is expected to exhibit a CAGR of 9.6% during the forecast period (2025-2032). Personalized medicine aims to tailor healthcare to the individual characteristics of each pati... View more

Scaffold Technology Market

Published Date : Feb 2025

Global scaffold technology market is estimated to be valued at USD 2.31 Bn in 2025 and is expected to exhibit a CAGR of 12.7% during the forecast period (2025-2032). Scaffold technology is a vital component of tissue engineering that provides a temporary structure f... View more

Fish Vaccine Market

Published Date : Feb 2025

Global fish vaccine market has witnessed steady growth in the past few years, owing to rise in aquaculture industry and increasing prevalence of deadly fish diseases. Fish vaccines help prevent fish populations from infectious diseases, thus, avoiding heavy economic l... View more

Dna Extraction Kits Market

Published Date : Feb 2025

The global DNA extraction kits market is estimated to be valued at USD 1,756.9 Mn in 2025 and is expected to exhibit a CAGR of 8.3% during the forecast period (2025-2032). DNA extraction kits are essential tools used to isolate DNA from biological samples. DNA, or d... View more

Research Antibodies Market

Published Date : Feb 2025

Global research antibodies market has been witnessing significant growth over the past few years, owing to increasing adoption of antibodies across various end-use sectors including pharmaceutical and biotechnology companies, academic institutes, contract research org... View more

Protein Engineering Market

Published Date : Feb 2025

Protein engineering is the process of developing useful proteins through rational or evolutionary design. It employs techniques, such as site-directed mutagenesis, chimeric construction, and random mutagenesis, to develop desired protein structures and functions. The ... View more